GENEVA, July 1 -- MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (HofgartenstraBe 880539 Munchen), MASSACHUSETTS INSTITUTE OF TECHNOLOGY (77 Massachusetts AvenueCambridge, Massachusetts 02139) filed a patent application (PCT/EP2024/087049) for "ANTIBODIES THAT BLOCK HIV1 CAPSID ENTRY INTO AN FG PHASE, TARGETING TO AND PASSAGE THROUGH NUCLEAR PORE COMPLEXES" on Dec 18, 2024. With publication no. WO/2025/132544, the details related to the patent application was published on Jun 26, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): GORLICH, Dirk (c/o Max-Planck-Institut fur Multidi...